Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Ipsen enters agreement with PregLem to develop reproductive medicines

June 29, 2007

Positive preclinical assessment for the antidiabetic compound LY-2463665

June 29, 2007

Natural product shows in vitro potential to prevent diabetic cataract

June 29, 2007

Actos filed for use in combination with insulin in Japan

June 28, 2007

Positive results with novel selective PPARalpha agonist in diabetic monkeys

June 28, 2007

PSN-119-1: A GPR119 receptor agonist with antidiabetic and antiobesity properties

June 28, 2007

DPP-IV inhibition with S-40010 enhances pancreatic beta-cell mass and reduces postprandrial glycemia

June 28, 2007

Novel SGLT inhibitors reduce postprandrial hyperglycemia in diabetic rats

June 28, 2007

OBE-101 phase II obesity trial completes treatment

June 28, 2007

Recent patents disclose novel agents for obesity and lipoprotein metabolism disorders

June 27, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...